Symmetry of Post-Translational Modifications in a Human Enzyme
Open Access
- 22 January 2022
- Vol. 14 (2), 212
- https://doi.org/10.3390/sym14020212
Abstract
Paraoxonase 2 (PON2) is a member of a small family of human lactonases. Recently, post-translational modifications (PTMs) of PON2 were highlighted, one of which involved the modulation of the enzyme activity. Furthermore, two important single nucleotide polymorphisms (SNPs) involved in type 2 diabetes and its consequences, were found to modulate the enzyme activity as well. The position on the PON2 structural model of both residues corresponding to SNPs and PTMs suggested a symmetry of the molecule. By sequence and structure superposition we were able to confirm this finding. The result will be discussed in light of the evolution of symmetry in biological molecules and their function.Keywords
Funding Information
- Ministry of University and Research (POC01_00042)
This publication has 56 references indexed in Scilit:
- β-Propeller Blades as Ancestral Peptides in Protein EvolutionPLOS ONE, 2013
- Acyl-Homoserine Lactone Quorum Sensing: From Evolution to ApplicationAnnual Review of Microbiology, 2013
- The Language of Histone CrosstalkCell, 2010
- Detecting internally symmetric protein structuresBMC Bioinformatics, 2010
- The Signaling Mechanisms Underlying Cell Polarity and ChemotaxisCold Spring Harbor Perspectives in Biology, 2009
- Emergence of symmetry in homooligomeric biological assembliesProceedings of the National Academy of Sciences of the United States of America, 2008
- Dominant Role of Paraoxonases in Inactivation of the Pseudomonas aeruginosa Quorum-Sensing Signal N -(3-Oxododecanoyl)- l -Homoserine LactoneInfection and Immunity, 2008
- Reconstruction of Functional β-Propeller Lectins via Homo-oligomeric Assembly of Shorter FragmentsJournal of Molecular Biology, 2007
- Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificitiesJournal of Lipid Research, 2005
- The paraoxonase gene family and atherosclerosisFree Radical Biology & Medicine, 2005